类固醇在三叉神经痛患者急性疼痛管理中可能的作用
本研究回顾性分析了2014至2020年因三叉神经痛急性发作至三级医疗机构急诊就诊的151例患者,其中40例(26.5%)在入院前和/或出院前接受了类固醇治疗。接受类固醇的患者接受手术治疗急性疼痛的可能性较低(P=0.023),出院时Barrow神经学研究所疼痛评分较低(P=0.013),出院后6个月内接受手术干预的可能性也较低(P=0.033)。作者认为类固醇可能降低三叉神经痛急性发作患者住院期间及出院后6个月内接受手术干预的可能性,未来需前瞻性研究检验其作为辅助药物的疗效。
要点
- 接受类固醇的三叉神经痛急性发作患者接受手术治疗急性疼痛的可能性较低(P=0.023)。
- 接受类固醇的患者出院时Barrow神经学研究所疼痛评分低于未接受类固醇者(P=0.013)。
- 接受类固醇的患者出院后6个月内接受手术干预的可能性较低(P=0.033)。
核心结论
- 三叉神经痛急性疼痛发作患者接受类固醇治疗可能降低住院期间及出院后6个月内接受手术干预的可能性。
- 未来前瞻性研究应检验类固醇作为三叉神经痛急性疼痛管理辅助药物的疗效。
研究设计与样本
- 回顾性研究,纳入2014年至2020年至三级医疗机构急诊就诊的三叉神经痛急性疼痛发作患者151例,分为接受类固醇组(40例,26.5%)与未接受类固醇组。
主要发现
- 接受类固醇的患者接受手术治疗急性疼痛的可能性较低(P=0.023)。
- 接受类固醇的患者接受甘油联合射频毁损术的可能性低于未接受类固醇者(P=0.012)。
- 两组阿片类药物给药频率和剂量无差异。
- 接受类固醇组出院时平均Barrow神经学研究所疼痛评分低于未接受类固醇组(P=0.013)。
- 接受类固醇的患者出院后6个月内接受手术干预的可能性低于未接受类固醇者(P=0.033)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Effective therapies for acute pain management in trigeminal neuralgia (TN) are limited. We aimed to investigate the role of steroids in TN patients experiencing acute pain flares. METHODS: We retrospectively reviewed patients presenting to the emergency department of a tertiary care institution between 2014 and 2020 for acute TN pain flares. Patients were divided into those who received steroids versus those who did not. Presenting characteristics, admission and surgical intervention rates, Barrow Neurological Institute pain scores, pain recurrence rates, and surgical intervention within 6 months of discharge were obtained for each patient. RESULTS: Our cohort comprised 151 patients, of whom 40 (26.5%) received steroids before admission and/or discharge. These patients were less likely to undergo surgical intervention to treat acute pain (P = 0.023). Specifically, patients receiving steroids were less likely to undergo combined glycerin and radiofrequency rhizotomy compared with patients not receiving steroids (P = 0.012). Frequency and dosage of opioid administration did not differ between groups. The steroids group demonstrated a lower average Barrow Neurological Institute pain score on discharge compared with the no steroids group (P = 0.013). Patients receiving steroids for acute pain management were less likely to undergo surgical intervention within 6 months of discharge than patients who did not receive steroids (P = 0.033). CONCLUSIONS: Steroid administration in patients with acute TN pain flares may reduce the likelihood of surgical intervention both during admission and within 6 months of discharge. Future prospective studies should examine the efficacy of steroids as an adjunctive medication in acute TN pain management.
引用
- Xu R, Nair SK, Shah PP, et al. A Potential Role for Steroids in Acute Pain Management in Patients with Trigeminal Neuralgia. World Neurosurg. 2022. PMID: 36113711. doi:10.1016/j.wneu.2022.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。